Cite
HARVARD Citation
Stein, K. et al. (2022). Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease. European journal of gastroenterology & hepatology. 34 (1), p. . [Online].